GLOBAL LIVER INSTITUTE
On Friday, April 4, 2025, the U.S. Centers for Medicare and Medicaid (CMS) released the 2026 Medicare Advantage and Part D Final Rule and decided not to finalize the proposed rule to extend obesity treatment coverage to Medicare and Medicaid beneficiaries.
Medicaid cuts are still under consideration in Congress as the House pushes for the Senate to accept its version of a budget reconciliation package.
Join us on Monday, April 21, 2025, at 3:00 PM PST | 6:00 PM EST for GLI’s Liver Cancer Lessons: Liver Disease Prevention Through Nutrition, an educational webinar that discusses the impact nutrition has on liver health.
Global Liver Institute is excited to announce the appointment of Dr. Sharon Jaycox as the new Fatty Liver Disease Program Director.
Growing up in rural Mississippi, MiKayla believed that opportunities in science were reserved for people from well-connected backgrounds.
Hepatitis B is a liver infection caused by the hepatitis B virus (HBV) that can cause long-term (chronic) disease. Chronic hepatitis B can lead to serious liver damage – including scarring (cirrhosis), liver failure, and even liver cancer.
Global Liver Institute (GLI) and King’s College Hospital NHS Foundation Trust (KCH) are proud to announce the first Advanced Advocacy Academy (A3) in the United Kingdom, an innovative program dedicated to increasing education, awareness, and advocacy for liver health.
The situation in Congress remains unclear as the House budget resolution calls for possible significant Medicaid cuts, while the Senate attempts to steer clear of policies reducing Medicaid and/or Medicare benefits.
As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.
February is Rare Liver Diseases Month! This year, our campaign is shining a spotlight on Rare and Rural.
Liver cancer continues to be a growing public health concern, with new research and treatment innovations shaping the future of care. This newsletter brings you the latest advancements in the field, including promising therapies, diagnostic breakthroughs, and discussions on the rising impact of metabolic and alcohol-related liver diseases. Stay informed with expert insights and emerging strategies that could improve patient outcomes.
Hepatitis C infection is a chronic infection of the liver by the hepatitis C virus (HCV) that continues to affect millions of people across the globe. Left untreated, infection with hepatitis C leads to worsening liver damage and puts the body in distress, which can lead to brain fog, abdominal pain, and internal bleeding.
